The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system
Abstract Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional protein that controls the cellular response to oxidative stress and possesses DNA-repair functions. It has important roles in the progression and outcomes of various diseases; however, its function and therapeutic prospects wi...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa537171877b4893a52a547f79f37b75 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:aa537171877b4893a52a547f79f37b75 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:aa537171877b4893a52a547f79f37b752021-12-02T15:08:09ZThe antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system10.1038/s41598-019-44241-z2045-2322https://doaj.org/article/aa537171877b4893a52a547f79f37b752019-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-019-44241-zhttps://doaj.org/toc/2045-2322Abstract Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional protein that controls the cellular response to oxidative stress and possesses DNA-repair functions. It has important roles in the progression and outcomes of various diseases; however, its function and therapeutic prospects with respect to kidney injury are unknown. To study this, we activated APE1 during kidney injury by constructing an expression vector (pCAG-APE1), using an EGFP expression plasmid (pCAG-EGFP) as a control. We performed unilateral ureteral obstruction (UUO) as a model of tubulointerstitial fibrosis on ICR mice before each vector was administrated via retrograde renal vein injection. In this model, pCAG-APE1 injection did not produce any adverse effects and significantly reduced histological end points including fibrosis, inflammation, tubular injury, and oxidative stress, as compared to those parameters after pCAG-EGFP injection. qPCR analysis showed significantly lower expression of Casp3 and inflammation-related genes in pCAG-APE1-injected animals compared to those in pCAG-EGFP-injected UUO kidneys. RNA-Seq analyses showed that the major transcriptional changes in pCAG-APE1-injected UUO kidneys were related to immune system processes, metabolic processes, catalytic activity, and apoptosis, leading to normal kidney repair. Therefore, APE1 suppressed renal fibrosis, not only via antioxidant and DNA-repair functions, but also partly by modulating the immune system through multiple pathways including Il6, Tnf, and chemokine families. Thus, therapeutic APE1 modulation might be beneficial for the treatment of renal diseases.Keisuke MaruyamaNaoki NakagawaTatsuya AonumaYukihiro SaitoTaiki HayasakaKohei KanoKiwamu HoriuchiNaofumi TakeharaJun-ichi KawabeNaoyuki HasebeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 9, Iss 1, Pp 1-11 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Keisuke Maruyama Naoki Nakagawa Tatsuya Aonuma Yukihiro Saito Taiki Hayasaka Kohei Kano Kiwamu Horiuchi Naofumi Takehara Jun-ichi Kawabe Naoyuki Hasebe The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system |
description |
Abstract Apurinic/apyrimidinic endonuclease 1 (APE1) is a multifunctional protein that controls the cellular response to oxidative stress and possesses DNA-repair functions. It has important roles in the progression and outcomes of various diseases; however, its function and therapeutic prospects with respect to kidney injury are unknown. To study this, we activated APE1 during kidney injury by constructing an expression vector (pCAG-APE1), using an EGFP expression plasmid (pCAG-EGFP) as a control. We performed unilateral ureteral obstruction (UUO) as a model of tubulointerstitial fibrosis on ICR mice before each vector was administrated via retrograde renal vein injection. In this model, pCAG-APE1 injection did not produce any adverse effects and significantly reduced histological end points including fibrosis, inflammation, tubular injury, and oxidative stress, as compared to those parameters after pCAG-EGFP injection. qPCR analysis showed significantly lower expression of Casp3 and inflammation-related genes in pCAG-APE1-injected animals compared to those in pCAG-EGFP-injected UUO kidneys. RNA-Seq analyses showed that the major transcriptional changes in pCAG-APE1-injected UUO kidneys were related to immune system processes, metabolic processes, catalytic activity, and apoptosis, leading to normal kidney repair. Therefore, APE1 suppressed renal fibrosis, not only via antioxidant and DNA-repair functions, but also partly by modulating the immune system through multiple pathways including Il6, Tnf, and chemokine families. Thus, therapeutic APE1 modulation might be beneficial for the treatment of renal diseases. |
format |
article |
author |
Keisuke Maruyama Naoki Nakagawa Tatsuya Aonuma Yukihiro Saito Taiki Hayasaka Kohei Kano Kiwamu Horiuchi Naofumi Takehara Jun-ichi Kawabe Naoyuki Hasebe |
author_facet |
Keisuke Maruyama Naoki Nakagawa Tatsuya Aonuma Yukihiro Saito Taiki Hayasaka Kohei Kano Kiwamu Horiuchi Naofumi Takehara Jun-ichi Kawabe Naoyuki Hasebe |
author_sort |
Keisuke Maruyama |
title |
The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system |
title_short |
The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system |
title_full |
The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system |
title_fullStr |
The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system |
title_full_unstemmed |
The antioxidant and DNA-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system |
title_sort |
antioxidant and dna-repair enzyme apurinic/apyrimidinic endonuclease 1 limits the development of tubulointerstitial fibrosis partly by modulating the immune system |
publisher |
Nature Portfolio |
publishDate |
2019 |
url |
https://doaj.org/article/aa537171877b4893a52a547f79f37b75 |
work_keys_str_mv |
AT keisukemaruyama theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT naokinakagawa theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT tatsuyaaonuma theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT yukihirosaito theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT taikihayasaka theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT koheikano theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT kiwamuhoriuchi theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT naofumitakehara theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT junichikawabe theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT naoyukihasebe theantioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT keisukemaruyama antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT naokinakagawa antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT tatsuyaaonuma antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT yukihirosaito antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT taikihayasaka antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT koheikano antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT kiwamuhoriuchi antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT naofumitakehara antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT junichikawabe antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem AT naoyukihasebe antioxidantanddnarepairenzymeapurinicapyrimidinicendonuclease1limitsthedevelopmentoftubulointerstitialfibrosispartlybymodulatingtheimmunesystem |
_version_ |
1718388271594078208 |